This is the first recorded case of generalized plane xanthomata associated with macroglobulinemia. There is no way of predicting whether this macroglobulin heralds malignancy but certain facts emerge from analysis of those 15 patients with myelomatosis so far recorded. Age of onset varied from 47 to 74 years of age, which is normal for this disease; but there were 9 male to 6 female patients, whereas the sex incidence in myeloma is normally equal. Thirteen patients developed xanthomata before the myelomatosis became evident, at intervals ranging from six months to eighteen years. High serum cholesterol, either alone or with high serum triglyceride was found in 10 patients; the remaining 5 were normolipemic.
There are few data on the survival of these patients; of the 7 who died, 5 died from recurrent chest infection within six years of the myeloma being discovered and two died from acute myocardial infarction. Our patient has had macroglobulinemia for five years to our knowledge but remains symptomatically well and is receiving no therapy.
Treatment is not indicated until the macroglobulinemia shows signs of malignancy, e.g. hemorrhage or hyperviscosity syndrome. The reports mentioned above suggest that this may not occur for some considerable time, if at all. Dr M Feiwel: The concept of generalized plane xanthoma and association with dysproteinwmias has evolved from cases shown to this Section by Borrie (1958) , Marten (1962) and McKenzie (1964) , and from parlers by the Mayo Clinic workers (Lynch & Winkelmann 1966) . Winkelmann holds that the xanthomatous infiltrate is an accompaniment occasionally to be expected in disorders of reticuloendothelial origin. On the other hand, its occurrence with paraproteinmmias suggests possible influence of immunoglobulins acting as autoantibodies to induce xanthomatosis (Feiwel 1968 , Kodama et al. 1972 . REFERENCES A S, woman aged 26 History: Three years ago she was found to have severe hypertension, which proved very difficult to control. Nine months ago the hypertension was stabilized after a course of intravenous diazoxide and she was then maintained on oral diazoxide 150 mg q.d.s. She is now also on frusemide, tolbutamide, propranolol and bethanidine.
After taking oral diazoxide for three months, she noticed increasing hairiness of face and arms.
Shortly after this she developed an acute eruption on face and chest, which has persisted.
On examination: Diffuse, fine, silky-yellow, lanugo-type hypertrichosis on face, neck and forearms. Lichenoid, slightly scaly papules on face, follicular lesions on chest (Figs 1 and 2) . Investigations: Blood urea 68 mg/100 ml, creatinine clearance 54 ml/min. Other investigations, in particular tests of thyroid, adrenal and liver function, are within normal limits.
Histological examination of a biopsy from one of the lesions on her upper chest showed an extensive, lichenoid band-like infiltrate in the upper dermis which was disrupting the dermoepidermal junction with resulting pigmentary incontinence. Diazoxide is a nondiuretic benzothiazide derivative closely related to the other thiazides, and it is a potent hypotensive agent. The thiazides are known to cause photosensitive, lichen-planuslike eruptions (Haber et al. 1959) and, although the skin eruption may have been produced by one of the other drugs, it is likely that the diazoxide was also responsible for the lichenoid eruption in this patient.
The cause of the hypertrichosis in diazoxidetreated patients is not known. As with hypertrichosis associated with internal malignancy, there is no detectable abnormality of endocrine function. Reversion to an undifferentiated mantletype hair, as found in almost all recently reported cases with internal neoplasm (Hegedus & Schoor 1972) , was not seen in our patient. Dr Louis Forman: Diazoxide can cause glycogen release from the liver and may also damage the liver, withjaundice; whether it can induce hepatic porphyria I do not know. With light sensitivity and hypertrichosis due to diazoxide therapy, it may be that the hypertrichosis is provoked by the light sensitivity, with or without porphyria, or that it is due to an abnormal androgen metabolite. Lichen planus may be drug induced or idiopathic; in either case lichen planus can be localized on the face by diazoxide-induced light sensitivity (cf. lichen planus tropicalis). The patient, who is of Italian parentage, was previously presented to this Section by Milla (1972) . First admission (aged 2 months): Widespread skin eruptIon typical of acrodermatitis enteropathica. A five-day course of biotin (10 mg daily) had no effect on her skin. Shortly after admission she developed a persistent watery diarrhoea due to lactose intolerance. After starting on a diet of Galactomin glucose with Ketovite supplements and Diodoquin 900 mg daily she improved and was discharged one month later, her skin almost clear.
Second admission (aged 11 to 15 months): Considerable difficulty was encountered both in the management of her diet and control of skin lesions. Disaccharide intolerance was again demonstrated. In spite of a one-week course of vitamin E and increasing the dose of Diodoquin to 7.2 g daily, her skin did not improve. Galactomin glucose feeds were then replaced by Galactomin fructose, to which were slowly added oral Intralipid and an L-aminoacid mixture, but introduction of chicken mixture (whole protein) promptly caused severe diarrhcea and flare-up of skin lesions. Although the chicken mixture was immediately withdrawn, improvement in her skin occurred only when Galactomin fructose, Intralipid and L-aminoacid mixture were replaced by lactase-treated pooled breast milk. Her increasing age and appetite, together with the difficulty in obtaining adequate supplies of breast milk and
